Zinc Supplementation for Prevention of Acute Respiratory Infections in Infants: A Randomized Controlled Trial.
Indian Pediatr
;
2014 Oct; 51(10): 780-784
Artigo
em Inglês
| IMSEAR
| ID: sea-170843
ABSTRACT
Objective:
To study the effect of 2 weeks of prophylactic zinc supplementation on incidence and duration of acute respiratory infections.Design:
Randomized double blind controlled trial.Setting:
Community based; urban resettlement area in North- East Delhi, India.Participants:
272 children aged 6-11 months with acute respiratory infections. Children receiving zinc supplement within the past 3 months, severely malnourished, immuno-deficient, on steroid therapy, with severe illness requiring hospitalization, or children of families likely to migrate from the study area were excluded. Intervention Placebo (syrup base) or zinc (20 mg/5 mL elemental zinc as zinc sulfate) orally given for a period of 2 weeks. Main outcome measure(s) Incidence, type and duration of acute respiratory infections, and adverse effects.Results:
No effect on incidence of acute respiratory infections was noted. A decrease of 15% (0.78-0.94) in days and 12% (0.78- 0.94) in duration of episode in acute respiratory infections was observed. Incidence of acute lower respiratory infections decreased by 62% (0.26-0.36) and the effect remained for full five months of follow up. There were no drop outs due to side effects.Conclusions:
Prophylactic zinc supplementation for two weeks may reduce the morbidity due to acute lower respiratory infections but not overall rate of acute respiratory infections in infants aged 6-11 months in similar populations.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Revista:
Indian Pediatr
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS